一只猫的终末期肥厚型心肌病。
End-stage hypertrophic cardiomyopathy in a cat.
作者信息
White Andrew J M
机构信息
Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, Prince Edward Island C1A 4P3.
出版信息
Can Vet J. 2015 May;56(5):509-11.
Abstract
A 14-year-old Persian cat was referred for evaluation of the progression of hypertrophic cardiomyopathy (HCM) after an acute episode of congestive heart failure. The diagnosis of HCM had been made almost 13 years ago. Echocardiography and electrocardiography revealed end-stage hypertrophic cardiomyopathy and multifocal atrial tachycardia. The patient was discharged on medical management with a grave prognosis.
摘要
一只14岁的波斯猫因在急性充血性心力衰竭发作后肥厚型心肌病（HCM）病情进展而前来接受评估。HCM的诊断几乎是在13年前做出的。超声心动图和心电图显示为终末期肥厚型心肌病和多灶性房性心动过速。该患者经药物治疗后出院，预后不佳。
相似文献
1
End-stage hypertrophic cardiomyopathy in a cat.一只猫的终末期肥厚型心肌病。
Can Vet J. 2015 May;56(5):509-11.
2
Effect of treatment with atenolol on 5-year survival in cats with preclinical (asymptomatic) hypertrophic cardiomyopathy.阿替洛尔治疗对临床前期（无症状）肥厚型心肌病猫5年生存率的影响。
J Vet Cardiol. 2013 Jun;15(2):93-104. doi: 10.1016/j.jvc.2013.03.003. Epub 2013 May 15.
3
Acute effects of ivabradine on dynamic obstruction of the left ventricular outflow tract in cats with preclinical hypertrophic cardiomyopathy.伊伐布雷定对临床前期肥厚型心肌病猫左心室流出道动态梗阻的急性影响。
J Vet Intern Med. 2014 May-Jun;28(3):838-46. doi: 10.1111/jvim.12331. Epub 2014 Mar 5.
4
Case-control study of the effects of pimobendan on survival time in cats with hypertrophic cardiomyopathy and congestive heart failure.匹莫苯丹对肥厚型心肌病和充血性心力衰竭猫生存时间影响的病例对照研究。
J Am Vet Med Assoc. 2014 Sep 1;245(5):534-9. doi: 10.2460/javma.245.5.534.
5
Effect of atenolol on heart rate, arrhythmias, blood pressure, and dynamic left ventricular outflow tract obstruction in cats with subclinical hypertrophic cardiomyopathy.阿替洛尔对亚临床肥厚型心肌病猫的心率、心律失常、血压及动态左心室流出道梗阻的影响。
J Vet Cardiol. 2015 Dec;17 Suppl 1:S296-305. doi: 10.1016/j.jvc.2015.03.002.
6
Effects of clopidogrel therapy on whole blood platelet aggregation, the Plateletworks® assay and coagulation parameters in cats with asymptomatic hypertrophic cardiomyopathy: a pilot study.氯吡格雷治疗对无症状肥厚型心肌病猫全血血小板聚集、Plateletworks® 检测和凝血参数的影响：一项初步研究。
Vet Q. 2017 Dec;37(1):8-15. doi: 10.1080/01652176.2016.1244618. Epub 2016 Oct 27.
7
Atenolol in cats with subclinical hypertrophic cardiomyopathy: a double-blind, placebo-controlled, randomized clinical trial of effect on quality of life, activity, and cardiac biomarkers.阿替洛尔用于亚临床肥厚型心肌病猫：一项关于对生活质量、活动及心脏生物标志物影响的双盲、安慰剂对照、随机临床试验。
J Vet Cardiol. 2020 Aug;30:77-91. doi: 10.1016/j.jvc.2020.06.002. Epub 2020 Jul 1.
8
Diagnosis and treatment of congestive heart failure secondary to hypertrophic cardiomyopathy in a kinkajou (Potos flavus).
J Zoo Wildl Med. 2010 Jun;41(2):342-5. doi: 10.1638/2009-0142R3.1.
9
The use of enalapril in the treatment of feline hypertrophic cardiomyopathy.依那普利在猫肥厚性心肌病治疗中的应用。
J Am Anim Hosp Assoc. 1998 Jan-Feb;34(1):38-41. doi: 10.5326/15473317-34-1-38.
10
Atenolol and survival in cats with asymptomatic hypertrophic cardiomyopathy.阿替洛尔与无症状性肥厚型心肌病猫的生存率
Vet Rec. 2016 Aug 13;179(7):176. doi: 10.1136/vr.i3837.
引用本文的文献
1
Exploration of Mediators Associated with Myocardial Remodelling in Feline Hypertrophic Cardiomyopathy.猫肥厚型心肌病中心肌重塑相关介质的探索
Animals (Basel). 2023 Jun 26;13(13):2112. doi: 10.3390/ani13132112.
2
The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy.猫心肌病：2. 肥厚型心肌病。
J Feline Med Surg. 2021 Nov;23(11):1028-1051. doi: 10.1177/1098612X211020162.
3
Effects of atenolol on left atrial and left ventricular function in healthy cats and in cats with hypertrophic cardiomyopathy.阿替洛尔对健康猫和肥厚型心肌病猫左心房及左心室功能的影响。
J Vet Med Sci. 2020 May 15;82(5):546-552. doi: 10.1292/jvms.19-0670. Epub 2020 Mar 19.
本文引用的文献
1
Multicenter evaluation of plasma N-terminal probrain natriuretic peptide (NT-pro BNP) as a biochemical screening test for asymptomatic (occult) cardiomyopathy in cats.多中心评估血浆 N 末端脑利钠肽前体（NT-proBNP）作为猫无症状（隐匿性）心肌病的生化筛选试验。
J Vet Intern Med. 2011 Sep-Oct;25(5):1010-6. doi: 10.1111/j.1939-1676.2011.00776.x. Epub 2011 Aug 30.
2
Utility of measuring plasma N-terminal pro-brain natriuretic peptide in detecting hypertrophic cardiomyopathy and differentiating grades of severity in cats.测量猫血浆N末端脑钠肽前体在检测肥厚型心肌病及区分严重程度分级中的作用
Vet Clin Pathol. 2011 Jun;40(2):237-44. doi: 10.1111/j.1939-165X.2011.00305.x. Epub 2011 Mar 24.
3
Prevalence of cardiomyopathy in apparently healthy cats.表面健康的猫心肌病的患病率。
J Am Vet Med Assoc. 2009 Jun 1;234(11):1398-403. doi: 10.2460/javma.234.11.1398.
4
Pathology of end-stage remodeling in a family of cats with hypertrophic cardiomyopathy.患有肥厚型心肌病的猫家族中终末期重塑的病理学
Vet Pathol. 2005 Jul;42(4):458-67. doi: 10.1354/vp.42-4-458.
5
Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990-1999).肥厚型心肌病猫的种群与生存特征：260例病例（1990 - 1999年）
J Am Vet Med Assoc. 2002 Jan 15;220(2):202-7. doi: 10.2460/javma.2002.220.202.
6
Natural history of hypertrophic cardiomyopathy and aortic thromboembolism in a family of domestic shorthair cats.一家家养短毛猫中肥厚型心肌病和主动脉血栓栓塞的自然病史。
J Vet Intern Med. 2001 Nov-Dec;15(6):595-9. doi: 10.1892/0891-6640(2001)015<0595:nhohca>2.3.co;2.
7
Familial hypertrophic cardiomyopathy in maine coon cats: an animal model of human disease.缅因猫家族性肥厚型心肌病：人类疾病的动物模型。
Circulation. 1999 Jun 22;99(24):3172-80. doi: 10.1161/01.cir.99.24.3172.
Zotero 插件